BBIO
Bridgebio Pharma Inc
$23.24
Earnings Summary
Revenue | $2.73Mn |
Net Profits | $-162.04Mn |
Net Profit Margins | -5931.19% |
Highlights
Bridgebio Pharma Inc’s revenue fell -33.22% since last year same period to $2.73Mn in the Q3 2024. On a quarterly growth basis, Bridgebio Pharma Inc has generated 26.01% jump in its revenue since last 3-months.
Bridgebio Pharma Inc’s net profit jumped 8.45% since last year same period to $-162.04Mn in the Q3 2024. On a quarterly growth basis, Bridgebio Pharma Inc has generated -120.59% fall in its net profits since last 3-months.
Bridgebio Pharma Inc’s net profit margin fell -37.09% since last year same period to -5931.19% in the Q3 2024. On a quarterly growth basis, Bridgebio Pharma Inc has generated -75.05% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Bridgebio Pharma Inc post its latest quarter earnings
EPS Estimate Current Year | -0.89 |
Highlights
Bridgebio Pharma Inc’s earning per share (EPS) estimates for the current year stand at -0.89.
Key Ratios
Key ratios of the Bridgebio Pharma Inc post its Q3 2024 earnings
Earning Per Share (EPS) | -0.86 |
Highlights
Bridgebio Pharma Inc’s earning per share (EPS) jumped 20.41% since last year same period to -0.86 in the Q3 2024. This indicates that the Bridgebio Pharma Inc has generated 20.41% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-08-01 | -1.06 | -0.39 | 63.21% |
2024-05-02 | -0.71 | -0.2 | 71.83% |
2024-09-30 | -0.98 | -0.86 | 12.29% |
₹0 US Stocks a/c Opening Fee